BR9504119A - Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica - Google Patents
Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmicaInfo
- Publication number
- BR9504119A BR9504119A BR9504119A BR9504119A BR9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A BR 9504119 A BR9504119 A BR 9504119A
- Authority
- BR
- Brazil
- Prior art keywords
- infection
- treating
- pharmaceutical composition
- mycoplasmic
- compound pharmaceutical
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31128594A | 1994-09-22 | 1994-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9504119A true BR9504119A (pt) | 1996-08-06 |
Family
ID=23206224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9504119A BR9504119A (pt) | 1994-09-22 | 1995-09-21 | Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU3121095A (pt) |
| BR (1) | BR9504119A (pt) |
| CO (1) | CO4410328A1 (pt) |
| IL (1) | IL115312A0 (pt) |
| WO (1) | WO1996009312A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605599B1 (en) | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
| US20020111317A1 (en) * | 2000-09-25 | 2002-08-15 | Leonard Katz | Sixteen-membered macrolide compounds |
| AU2003218110A1 (en) | 2002-03-12 | 2003-09-29 | Bristol-Myers Squibb Company | C3-cyano epothilone derivatives |
| JP5323696B2 (ja) | 2006-07-28 | 2013-10-23 | インターベツト・インターナシヨナル・ベー・ベー | マクロライド合成方法 |
| JP6170064B2 (ja) | 2011-11-25 | 2017-07-26 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 抗菌性チロシン誘導体およびその製造方法 |
| NO2999707T3 (pt) | 2013-05-23 | 2018-08-25 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58146595A (ja) * | 1982-02-25 | 1983-09-01 | Satoshi Omura | マクロライド系抗生物質 |
| US4443436A (en) * | 1982-09-13 | 1984-04-17 | Eli Lilly And Company | C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin |
| AU561147B2 (en) * | 1982-09-13 | 1987-04-30 | Eli Lilly And Company | 20-amino macrolide antibiotics |
| JPS59181299A (ja) * | 1983-03-31 | 1984-10-15 | Microbial Chem Res Found | ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド |
| JPS59227897A (ja) * | 1983-06-10 | 1984-12-21 | Microbial Chem Res Found | ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換−マイカミノシルレロノライド |
| US4920103A (en) * | 1986-09-29 | 1990-04-24 | Eli Lilly And Company | Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides |
| TW226373B (pt) * | 1992-07-15 | 1994-07-11 | Pfizer | |
| WO1995002594A1 (en) * | 1993-07-15 | 1995-01-26 | Pfizer Inc. | Amide derivatives of 16-membered ring antibiotic macrolides |
-
1995
- 1995-08-17 AU AU31210/95A patent/AU3121095A/en not_active Abandoned
- 1995-08-17 WO PCT/IB1995/000661 patent/WO1996009312A1/en not_active Ceased
- 1995-09-08 CO CO95040999A patent/CO4410328A1/es unknown
- 1995-09-14 IL IL11531295A patent/IL115312A0/xx unknown
- 1995-09-21 BR BR9504119A patent/BR9504119A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL115312A0 (en) | 1995-12-31 |
| WO1996009312A1 (en) | 1996-03-28 |
| AU3121095A (en) | 1996-04-09 |
| CO4410328A1 (es) | 1997-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9500659A (pt) | Composto composição farmacêutica e método de tratamento ou prevenção de uma condição causada por uma injeção bacteriana | |
| BR9602001A (pt) | Composto composição farmacéutica método para inibição de metalproteinases método para o tratamento de uma condição | |
| BR9608773A (pt) | Tratamento bacteriano para silagem | |
| BR9504072A (pt) | Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit | |
| FI940932L (fi) | Koostumuksia ja menetelmiä haavojen hoitamiseksi | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| FI960751A7 (fi) | Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| BR9602628A (pt) | Composto composição farmacêutica método para o tratamento de uma condição e método para diminuir a secreção de apo b num mamífero | |
| DK0797551T3 (da) | Cementagtig sammensætning | |
| BR9610836A (pt) | Composição antibacterial para administração oral | |
| FI971750A7 (fi) | Koostumuksia multippeliskleroosia varten ja sen hoito | |
| BR9506642A (pt) | Composição e método para proteger uma plantação contra doenças patogênicas | |
| FI953369L (fi) | Farmaseuttiset koostumukset syöpäsairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi | |
| FI951856L (fi) | Farmaseuttinen koostumus osteoporoosin hoitamiseksi | |
| FI951060L (fi) | Formulaatioita ja hoitomenetelmiä | |
| BR9505995A (pt) | Composto método para tratamentos e composição farmacêutica | |
| BR9507768A (pt) | Composição farmacêutica | |
| BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
| BR9504119A (pt) | Composto composiçao farmacêutica métodos para tratar uma infecçao bacteriana e uma infecçao micoplásmica | |
| FI964271A7 (fi) | Menetelmä yhdisteen DX-52-1 stabiloimiseksi ja sen lyofilisoitu koostu mus | |
| FI933642A7 (fi) | Koostumus ja menetelmiä luun muodostamiseksi | |
| FI955123A0 (fi) | Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi | |
| FI953260A7 (fi) | Farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |